2LZL - JenaLib

NMR Structure - model 1 (Jmol Viewer)

NMR Structure - all models (Jmol Viewer)

Title :   FGFR3TM

Authors :   D. M. Lesovoy, E. V. Bocharov, S. A. Goncharuk, A. S. Arseniev

Date :   04 Oct 12 (Deposition) - 09 Oct 13 (Release) - 27 Nov 13 (Revision)

Method :   SOLUTION NMR

Resolution :   NOT APPLICABLE

Chains :   NMR Structure  : A,B  (25x)
NMR Structure *: A,B  (1x)

Keywords :   Transmembrane Domain, Fibroblast Growth Factor Receptor, Dimerization, Tyrosine Kinase, Membrane Protein (Keyword Search: [Gene Ontology, PubMed, Web (Google)] )

Reference :   E. V. Bocharov, D. M. Lesovoy, S. A. Goncharuk, M. V. Goncharuk, K. Hristova, A. S. Arseniev
Structure Of Fgfr3 Transmembrane Domain Dimer: Implications For Signaling And Human Pathologies.
Structure V. 21 2087 2013
PubMed-ID: 24120763 | Reference-DOI: 10.1016/J.STR.2013.08.026

Molecule 1 - FIBROBLAST GROWTH FACTOR RECEPTOR 3
	Chains	:	A, B
	EC Number	:	2.7.10.1
	Engineered	:	YES
	Expression System	:	ESCHERICHIA COLI
	Expression System Strain	:	BL21(DE3)PLYSS
	Expression System Taxid	:	469008
	Expression System Vector	:	PGEMEX-1/(TRX-TMFGFR3)
	Fragment	:	UNP RESIDUES 357-399
	Gene	:	FGFR3, JTK4
	Organism Common	:	HUMAN
	Organism Scientific	:	HOMO SAPIENS
	Organism Taxid	:	9606
	Synonym	:	FGFR-3

		1	2
NMR Structure (25x)	:	A	B
NMR Structure * (1x)	:	A	B

Summary Information (see also Sequences/Alignments below)

(no "Ligand,Modified Residues,Ions" information available for 2LZL)

(no "Site" information available for 2LZL)

(no "SS Bond" information available for 2LZL)

(no "Cis Peptide Bond" information available for 2LZL)

NMR Structure (7, 14)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_004151	G	370	C	FGFR3_HUMAN	Disease (TD1)	121913479	A/B	G	370	C
2	UniProt	VAR_004152	S	371	C	FGFR3_HUMAN	Disease (TD1)	121913484	A/B	S	371	C
3	UniProt	VAR_004153	Y	373	C	FGFR3_HUMAN	Disease (TD1)	121913485	A/B	Y	373	C
4	UniProt	VAR_004154	G	375	C	FGFR3_HUMAN	Disease (ACH)	75790268	A/B	G	375	C
5	UniProt	VAR_004155	G	380	R	FGFR3_HUMAN	Disease (KNEN)	28931614	A/B	G	380	R
6	UniProt	VAR_022168	F	384	L	FGFR3_HUMAN	Polymorphism	17881656	A/B	F	384	L
7	UniProt	VAR_004156	A	391	E	FGFR3_HUMAN	Disease (CAN)	28931615	A/B	A	391	E

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

NMR Structure * (7, 14)

								dbSNP	PDB
No.	Source	Variant ID	Variant			UniProt ID	Status	ID	Chain	Variant
1	UniProt	VAR_004151	G	370	C	FGFR3_HUMAN	Disease (TD1)	121913479	A/B	G	370	C
2	UniProt	VAR_004152	S	371	C	FGFR3_HUMAN	Disease (TD1)	121913484	A/B	S	371	C
3	UniProt	VAR_004153	Y	373	C	FGFR3_HUMAN	Disease (TD1)	121913485	A/B	Y	373	C
4	UniProt	VAR_004154	G	375	C	FGFR3_HUMAN	Disease (ACH)	75790268	A/B	G	375	C
5	UniProt	VAR_004155	G	380	R	FGFR3_HUMAN	Disease (KNEN)	28931614	A/B	G	380	R
6	UniProt	VAR_022168	F	384	L	FGFR3_HUMAN	Polymorphism	17881656	A/B	F	384	L
7	UniProt	VAR_004156	A	391	E	FGFR3_HUMAN	Disease (CAN)	28931615	A/B	A	391	E

SNP/SAP Summary Statistics (UniProtKB/Swiss-Prot)

(no "PROSITE Motif" information available for 2LZL)

NMR Structure (2, 4)

	ENSEMBL					UniProtKB			PDB
No.	Transcript ID	Exon	Exon ID	Genome Location	Length	ID	Location	Length	Count	Location	Length
1.2a	ENST00000260795	2a	ENSE00001596390	chr4:1795560-1795770	211	FGFR3_HUMAN	1-37	37	0	-	-
1.3	ENST00000260795	3	ENSE00001164902	chr4:1800981-1801250	270	FGFR3_HUMAN	37-127	91	0	-	-
1.4	ENST00000260795	4	ENSE00000778155	chr4:1801474-1801539	66	FGFR3_HUMAN	127-149	23	0	-	-
1.5a	ENST00000260795	5a	ENSE00000933877	chr4:1803094-1803263	170	FGFR3_HUMAN	149-205	57	0	-	-
1.6a	ENST00000260795	6a	ENSE00000778157	chr4:1803347-1803470	124	FGFR3_HUMAN	206-247	42	0	-	-
1.7b	ENST00000260795	7b	ENSE00000933879	chr4:1803562-1803752	191	FGFR3_HUMAN	247-310	64	0	-	-
1.9b	ENST00000260795	9b	ENSE00000778159	chr4:1805419-1805563	145	FGFR3_HUMAN	311-359	49	2	A:357-359 B:357-359	3 3
1.10a	ENST00000260795	10a	ENSE00000778160	chr4:1806057-1806247	191	FGFR3_HUMAN	359-422	64	2	A:359-399 B:359-399	41 41
1.10d	ENST00000260795	10d	ENSE00000843002	chr4:1806551-1806696	146	FGFR3_HUMAN	423-471	49	0	-	-
1.11	ENST00000260795	11	ENSE00001660253	chr4:1807082-1807203	122	FGFR3_HUMAN	471-512	42	0	-	-
1.12	ENST00000260795	12	ENSE00000778164	chr4:1807286-1807396	111	FGFR3_HUMAN	512-549	38	0	-	-
1.13b	ENST00000260795	13b	ENSE00001768214	chr4:1807477-1807667	191	FGFR3_HUMAN	549-612	64	0	-	-
1.14	ENST00000260795	14	ENSE00001604810	chr4:1807778-1807900	123	FGFR3_HUMAN	613-653	41	0	-	-
1.15	ENST00000260795	15	ENSE00001676483	chr4:1807984-1808054	71	FGFR3_HUMAN	654-677	24	0	-	-
1.16	ENST00000260795	16	ENSE00001745037	chr4:1808273-1808410	138	FGFR3_HUMAN	677-723	47	0	-	-
1.17	ENST00000260795	17	ENSE00001740590	chr4:1808556-1808661	106	FGFR3_HUMAN	723-758	36	0	-	-
1.18c	ENST00000260795	18c	ENSE00001769683	chr4:1808843-1810598	1756	FGFR3_HUMAN	759-806	48	0	-	-

NMR Structure

Reformat:	Number of residues per line = ('0' or empty: single-line sequence representation)
	Number of residues per labelling interval =
	UniProt sequence: complete aligned part

Show mapping:	SCOP domains	CATH domains	Pfam domains	Secondary structure (by author)
	SAPs(SNPs)	PROSITE motifs	Exons
	(details for a mapped element are shown in a popup box when the mouse pointer rests over it)

Chain A from PDB  Type:PROTEIN  Length:43
 aligned with FGFR3_HUMAN | P22607 from UniProtKB/Swiss-Prot  Length:806

    Alignment length:43
                                   366       376       386       396   
          FGFR3_HUMAN   357 LPAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLR 399
               SCOP domains ------------------------------------------- SCOP domains
               CATH domains ------------------------------------------- CATH domains
               Pfam domains ------------------------------------------- Pfam domains
         Sec.struct. author ...............hhhh.hhhhhhhhhhhhhhhhhhhh... Sec.struct. author
                 SAPs(SNPs) -------------CC-C-C----R---L------E-------- SAPs(SNPs)
                    PROSITE ------------------------------------------- PROSITE
           Transcript 1 (1) --Exon 1.10a  PDB: A:359-399 [INCOMPLETE]   Transcript 1 (1)
           Transcript 1 (2) 1.9---------------------------------------- Transcript 1 (2)
                 2lzl A 357 LPAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLR 399
                                   366       376       386       396

Chain B from PDB  Type:PROTEIN  Length:43
 aligned with FGFR3_HUMAN | P22607 from UniProtKB/Swiss-Prot  Length:806

    Alignment length:43
                                   366       376       386       396   
          FGFR3_HUMAN   357 LPAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLR 399
               SCOP domains ------------------------------------------- SCOP domains
               CATH domains ------------------------------------------- CATH domains
               Pfam domains ------------------------------------------- Pfam domains
         Sec.struct. author ...............hhhh........................ Sec.struct. author
                 SAPs(SNPs) -------------CC-C-C----R---L------E-------- SAPs(SNPs)
                    PROSITE ------------------------------------------- PROSITE
           Transcript 1 (1) --Exon 1.10a  PDB: B:359-399 [INCOMPLETE]   Transcript 1 (1)
           Transcript 1 (2) 1.9---------------------------------------- Transcript 1 (2)
                 2lzl B 357 LPAEEELVEADEAGSVYAGILSYGVGFFLFILVVAAVTLCRLR 399
                                   366       376       386       396

Legend:		→ Mismatch	(orange background)
	-	→ Gap	(green background, '-', border residues have a numbering label)
		→ Modified Residue	(blue background, lower-case, 'x' indicates undefined single-letter code, labelled with number + name)
	x	→ Chemical Group	(purple background, 'x', labelled with number + name, e.g. ACE or NH2)
	extra numbering lines below/above indicate numbering irregularities and modified residue names etc., number ends below/above '\|'

(no "SCOP Domain" information available for 2LZL)

(no "CATH Domain" information available for 2LZL)

(no "Pfam Domain" information available for 2LZL)

NMR Structure(hide GO term definitions)

Chain A,B (FGFR3_HUMAN | P22607)

molecular function
	GO:0016303	1-phosphatidylinositol-3-kinase activity	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol + ATP = a 1-phosphatidyl-1D-myo-inositol 3-phosphate + ADP + 2 H(+).
	GO:0005524	ATP binding	Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
	GO:0005088	Ras guanyl-nucleotide exchange factor activity	Stimulates the exchange of guanyl nucleotides associated with a GTPase of the Ras superfamily. Under normal cellular physiological conditions, the concentration of GTP is higher than that of GDP, favoring the replacement of GDP by GTP in association with the GTPase.
	GO:0017134	fibroblast growth factor binding	Interacting selectively and non-covalently with a fibroblast growth factor.
	GO:0005007	fibroblast growth factor-activated receptor activity	Combining with a fibroblast growth factor and transmitting the signal across the plasma membrane to initiate a change in cell activity.
	GO:0016301	kinase activity	Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
	GO:0000166	nucleotide binding	Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.
	GO:0046934	phosphatidylinositol-4,5-bisphosphate 3-kinase activity	Catalysis of the reaction: 1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate + ATP = a 1-phosphatidyl-1D-myo-inositol 3,4,5-trisphosphate + ADP + 2 H(+).
	GO:0005515	protein binding	Interacting selectively and non-covalently with any protein or protein complex (a complex of two or more proteins that may include other nonprotein molecules).
	GO:0004672	protein kinase activity	Catalysis of the phosphorylation of an amino acid residue in a protein, usually according to the reaction: a protein + ATP = a phosphoprotein + ADP.
	GO:0004713	protein tyrosine kinase activity	Catalysis of the reaction: ATP + a protein tyrosine = ADP + protein tyrosine phosphate.
	GO:0016740	transferase activity	Catalysis of the transfer of a group, e.g. a methyl group, glycosyl group, acyl group, phosphorus-containing, or other groups, from one compound (generally regarded as the donor) to another compound (generally regarded as the acceptor). Transferase is the systematic name for any enzyme of EC class 2.
	GO:0004714	transmembrane receptor protein tyrosine kinase activity	Combining with a signal and transmitting the signal from one side of the membrane to the other to initiate a change in cell activity by catalysis of the reaction: ATP + a protein-L-tyrosine = ADP + a protein-L-tyrosine phosphate.
biological process
	GO:0007259	JAK-STAT cascade	Any process in which STAT proteins (Signal Transducers and Activators of Transcription) and JAK (Janus Activated Kinase) proteins convey a signal to trigger a change in the activity or state of a cell. The JAK-STAT cascade begins with activation of STAT proteins by members of the JAK family of tyrosine kinases, proceeds through dimerization and subsequent nuclear translocation of STAT proteins, and ends with regulation of target gene expression by STAT proteins.
	GO:0000165	MAPK cascade	An intracellular protein kinase cascade containing at least a MAPK, a MAPKK and a MAP3K. The cascade can also contain two additional tiers: the upstream MAP4K and the downstream MAP Kinase-activated kinase (MAPKAPK). The kinases in each tier phosphorylate and activate the kinases in the downstream tier to transmit a signal within a cell.
	GO:0006915	apoptotic process	A programmed cell death process which begins when a cell receives an internal (e.g. DNA damage) or external signal (e.g. an extracellular death ligand), and proceeds through a series of biochemical events (signaling pathway phase) which trigger an execution phase. The execution phase is the last step of an apoptotic process, and is typically characterized by rounding-up of the cell, retraction of pseudopodes, reduction of cellular volume (pyknosis), chromatin condensation, nuclear fragmentation (karyorrhexis), plasma membrane blebbing and fragmentation of the cell into apoptotic bodies. When the execution phase is completed, the cell has died.
	GO:0070977	bone maturation	A developmental process, independent of morphogenetic (shape) change, that is required for bone to attain its fully functional state.
	GO:0030282	bone mineralization	The deposition of hydroxyapatite, a form of calcium phosphate with the formula Ca10(PO4)6(OH)2, in bone tissue.
	GO:0060349	bone morphogenesis	The process in which bones are generated and organized.
	GO:0007267	cell-cell signaling	Any process that mediates the transfer of information from one cell to another. This process includes signal transduction in the receiving cell and, where applicable, release of a ligand and any processes that actively facilitate its transport and presentation to the receiving cell. Examples include signaling via soluble ligands, via cell adhesion molecules and via gap junctions.
	GO:0002062	chondrocyte differentiation	The process in which a chondroblast acquires specialized structural and/or functional features of a chondrocyte. A chondrocyte is a polymorphic cell that forms cartilage.
	GO:0035988	chondrocyte proliferation	The multiplication or reproduction of chondrocytes by cell division, resulting in the expansion of their population. A chondrocyte is a polymorphic cell that forms cartilage.
	GO:0003416	endochondral bone growth	The increase in size or mass of an endochondral bone that contributes to the shaping of the bone.
	GO:0001958	endochondral ossification	Replacement ossification wherein bone tissue replaces cartilage.
	GO:1902178	fibroblast growth factor receptor apoptotic signaling pathway	An apoptotic signaling pathway that starts with a ligand binding to, or being withdrawn from, a fibroblast growth factor receptor (FGFR).
	GO:0008543	fibroblast growth factor receptor signaling pathway	The series of molecular signals generated as a consequence of a fibroblast growth factor receptor binding to one of its physiological ligands.
	GO:0048640	negative regulation of developmental growth	Any process that stops, prevents, or reduces the frequency, rate or extent of developmental growth.
	GO:0018108	peptidyl-tyrosine phosphorylation	The phosphorylation of peptidyl-tyrosine to form peptidyl-O4'-phospho-L-tyrosine.
	GO:0046854	phosphatidylinositol phosphorylation	The process of introducing one or more phosphate groups into a phosphatidylinositol, any glycerophosphoinositol having one phosphatidyl group esterified to one of the hydroxy groups of inositol.
	GO:0036092	phosphatidylinositol-3-phosphate biosynthetic process	The chemical reactions and pathways resulting in the formation of phosphatidylinositol-3-phosphate, a phosphatidylinositol monophosphate carrying the phosphate group at the 3-position.
	GO:0048015	phosphatidylinositol-mediated signaling	A series of molecular signals in which a cell uses a phosphatidylinositol-mediated signaling to convert a signal into a response. Phosphatidylinositols include phosphatidylinositol (PtdIns) and its phosphorylated derivatives.
	GO:0016310	phosphorylation	The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
	GO:0070374	positive regulation of ERK1 and ERK2 cascade	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the ERK1 and ERK2 cascade.
	GO:0043547	positive regulation of GTPase activity	Any process that activates or increases the activity of a GTPase.
	GO:0043410	positive regulation of MAPK cascade	Any process that activates or increases the frequency, rate or extent of signal transduction mediated by the MAPK cascade.
	GO:0008284	positive regulation of cell proliferation	Any process that activates or increases the rate or extent of cell proliferation.
	GO:0043552	positive regulation of phosphatidylinositol 3-kinase activity	Any process that activates or increases the frequency, rate or extent of phosphatidylinositol 3-kinase activity.
	GO:0010518	positive regulation of phospholipase activity	Any process that increases the frequency, rate or extent of phospholipase activity, the hydrolysis of a phospholipid.
	GO:0046777	protein autophosphorylation	The phosphorylation by a protein of one or more of its own amino acid residues (cis-autophosphorylation), or residues on an identical protein (trans-autophosphorylation).
	GO:0006468	protein phosphorylation	The process of introducing a phosphate group on to a protein.
	GO:0014066	regulation of phosphatidylinositol 3-kinase signaling	Any process that modulates the frequency, rate or extent of signal transduction mediated by the phosphatidylinositol 3-kinase cascade.
	GO:0001501	skeletal system development	The process whose specific outcome is the progression of the skeleton over time, from its formation to the mature structure. The skeleton is the bony framework of the body in vertebrates (endoskeleton) or the hard outer envelope of insects (exoskeleton or dermoskeleton).
cellular component
	GO:0005794	Golgi apparatus	A compound membranous cytoplasmic organelle of eukaryotic cells, consisting of flattened, ribosome-free vesicles arranged in a more or less regular stack. The Golgi apparatus differs from the endoplasmic reticulum in often having slightly thicker membranes, appearing in sections as a characteristic shallow semicircle so that the convex side (cis or entry face) abuts the endoplasmic reticulum, secretory vesicles emerging from the concave side (trans or exit face). In vertebrate cells there is usually one such organelle, while in invertebrates and plants, where they are known usually as dictyosomes, there may be several scattered in the cytoplasm. The Golgi apparatus processes proteins produced on the ribosomes of the rough endoplasmic reticulum; such processing includes modification of the core oligosaccharides of glycoproteins, and the sorting and packaging of proteins for transport to a variety of cellular locations. Three different regions of the Golgi are now recognized both in terms of structure and function: cis, in the vicinity of the cis face, trans, in the vicinity of the trans face, and medial, lying between the cis and trans regions.
	GO:0009986	cell surface	The external part of the cell wall and/or plasma membrane.
	GO:0005737	cytoplasm	All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
	GO:0031410	cytoplasmic vesicle	A vesicle found in the cytoplasm of a cell.
	GO:0005783	endoplasmic reticulum	The irregular network of unit membranes, visible only by electron microscopy, that occurs in the cytoplasm of many eukaryotic cells. The membranes form a complex meshwork of tubular channels, which are often expanded into slitlike cavities called cisternae. The ER takes two forms, rough (or granular), with ribosomes adhering to the outer surface, and smooth (with no ribosomes attached).
	GO:0005576	extracellular region	The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
	GO:0005925	focal adhesion	Small region on the surface of a cell that anchors the cell to the extracellular matrix and that forms a point of termination of actin filaments.
	GO:0016021	integral component of membrane	The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0005887	integral component of plasma membrane	The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
	GO:0016020	membrane	A lipid bilayer along with all the proteins and protein complexes embedded in it an attached to it.
	GO:0005634	nucleus	A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
	GO:0005886	plasma membrane	The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.
	GO:0030133	transport vesicle	Any of the vesicles of the constitutive secretory pathway, which carry cargo from the endoplasmic reticulum to the Golgi, between Golgi cisternae, from the Golgi to the ER (retrograde transport) or to destinations within or outside the cell.

NMR Structure
	Complete Structure
		Jena3D(integrated viewing of ligand, site, SAP, PROSITE, SCOP information)
		WebMol \| AstexViewer[tm]@PDBe (Java Applets, require no local installation except for Java; loading may be slow)
		STRAP (Java WebStart application, automatic local installation, requires Java; full application with system access!)
		RasMol (require local installation)
		Molscript (VRML) (requires installation of a VRML viewer; select preferred view via VRML and generate a mono or stereo PDF format file)

	Ligands, Modified Residues, Ions
(no "Ligands, Modified Residues, Ions" information available for 2lzl)

	Sites
(no "Sites" information available for 2lzl)

	Cis Peptide Bonds
(no "Cis Peptide Bonds" information available for 2lzl)

Jmol
	protein: cartoon or spacefill or dots and stick; nucleic acid: cartoon and stick; ligands: spacefill; active site: stick [ NMR Structure - model 1 PNG format \| NMR Structure - all models PNG format ](automatic orientation, automatically generated)
Molscript
	protein, nucleic acid: cartoon; ligands: spacefill; active site: ball and stick [ mono PDF format \| stereo PDF format ](default orientation, automatically generated)

Access by PDB/NDB ID
	2lzl
		Family and Domain Information	:	ProDom \| SYSTERS
		General Structural Information	:	GlycoscienceDB \| MMDB \| NDB \| OCA \| PDB \| PDBe \| PDBj \| PDBsum \| PDBWiki \| PQS \| PROTEOPEDIA
		Orientation in Membranes	:	OPM
		Protein Surface	:	SURFACE
		Secondary Structure	:	DSSP (structure derived) \| HSSP (homology derived)
		Structural Genomics	:	GeneCensus
		Structural Neighbours	:	CE \| VAST
		Structure Classification	:	CATH \| Dali \| SCOP
		Validation and Original Data	:	BMRB Data View \| BMRB Restraints Grid \| EDS \| PROCHECK \| RECOORD \| WHAT_CHECK

Access by UniProt ID/Accession number
	FGFR3_HUMAN \| P22607
		Comparative Protein Structure Models	:	ModBase
		Genomic Information	:	Ensembl
		Protein-protein Interaction	:	DIP
		Sequence, Family and Domain Information	:	InterPro \| Pfam \| SMART \| UniProtKB/SwissProt

Access by Enzyme Classificator (EC Number)
	2.7.10.1
		General Enzyme Information	:	BRENDA \| EC-PDB \| Enzyme \| IntEnz
		Pathway	:	KEGG \| MetaCyc

Access by Disease Identifier (MIM ID)
	100800
		Disease Information	:	OMIM
	162900
		Disease Information	:	OMIM
	187600
		Disease Information	:	OMIM
	612247
		Disease Information	:	OMIM

Access by GenAge ID
	(no 'GenAge ID' available)
		Age Related Information	:	GenAge

Access by PDB/NDB ID
		Domain Information	:	XDom
		Interatomic Contacts of Structural Units	:	CSU
		Ligand-protein Contacts	:	LPC
		Protein Cavities	:	castP
		Sequence and Secondary Structure	:	PDBCartoon
		Structure Alignment	:	STRAP(Java WebStart application, automatic local installation, requires Java; full application with system access!)
		Structure and Sequence Browser	:	STING

Access by UniProt ID/Accession number
	FGFR3_HUMAN \| P22607
		Protein Disorder Prediction	:	DisEMBL \| FoldIndex \| GLOBPLOT (for more information see DisProt)

UniProtKB/Swiss-Prot
	FGFR3_HUMAN \| P22607	:	1ry7 4k33

(no "Related Entries Specified in the PDB File" available for 2LZL)

Description

Compounds

Structural Features

Chains, Units

Ligands, Modified Residues, Ions (0, 0)

Sites (0, 0)

SS Bonds (0, 0)

Cis Peptide Bonds (0, 0)

Sequence-Structure Mapping

SAPs(SNPs)/Variants (7, 14)

PROSITE Motifs (0, 0)

Exons (2, 4)

Sequences/Alignments

Classification and Annotation

SCOP Domains (0, 0)

CATH Domains (0, 0)

Pfam Domains (0, 0)

Gene Ontology (55, 55)

Visualization

Interactive Views

Still Images

Databases and Analysis Tools

Databases

Analysis Tools

Related Entries

Entries Sharing at Least One Protein Chain (UniProt ID)

Related Entries Specified in the PDB File